Ajay O. Mehta
Nagpur, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical study.
Journal: Therapeutic advances in medical oncology
Published: July 20, 2023
Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 19, 2022
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial.
Journal: Breast cancer research and treatment
Published: September 11, 2021
Effect of Mindfulness-Based Art Therapy (MBAT) on Psychological Distress and Spiritual Wellbeing in Breast Cancer Patients Undergoing Chemotherapy.
Journal: Indian journal of palliative care
Published: July 12, 2021
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 26, 2020
Solitary Pancreatic Head Metastasis from Ductal Carcinoma of Breast: A Case Report.
Journal: Indian journal of surgical oncology
Published: May 18, 2020
A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 15, 2018
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.
Journal: JAMA oncology
Published: April 15, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026